RSSCategory: Government

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary H&E diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

Webinar: Philips IntelliSite Pathology Solution Now Available for Primary Diagnostic Use in the U.S.

| April 30, 2017 | 0 Comments

Thu, May 4th, 2017 11:00 AM EST (1 hour) As a leader in the field, Philips is a driver of the adoption of digital pathology. Our solution was developed with the aim to increase efficiency and collaboration in your clinical lab. We are very proud to announce the Philips Intellisite Pathology Solution is the first, […]

Continue Reading

162 Days of Change

| April 17, 2017 | 1 Comment

As of last Thursday, April 12, 2017 and going back to a rainy night in Cleveland on November 2, 2016, the past 162 days have seen at least 3 things most Americans, and perhaps many across the world thought they would never see happen in their lifetimes. That rainy night in Cleveland started the clock […]

Continue Reading

FDA Allows Marketing of First Whole Slide Imaging System for Digital Pathology

| April 13, 2017 | 1 Comment

Welcome news anticipated from FDA for some time with recent Philips submission for approval. Philips Intellisite Pathology Solution (PIPS) first WSI system approved with special controls on the system to insure patient safety. More to follow on FDA approval of WSI for clinical use! The U.S. Food and Drug Administration today permitted marketing of the […]

Continue Reading

DPA Companion Meeting to Take Place at 2017 Pathology Informatics Summit

| April 1, 2017 | 0 Comments

SAVE THE DATE! DPA COMPANION MEETING To take place at the 2017 Pathology Informatics Summit Monday, May 22, 2017 | 5:00-7:00 PM Wyndham Grand Pittsburgh Hotel | King’s Garden 2/3 Pittsburgh, PA Presentations Include: Quantitative Image Analysis for HER2 Immunohistochemistry for Breast Cancer: Guideline Update and – Review of Draft Recommendations by Dr. Marilyn Bui Primary Diagnosis […]

Continue Reading

The Restaurateur Who Thought Like a Pathologist

| March 21, 2017 | 0 Comments

Again, the talk of not healthcare reform but rather healthcare payment reform and the interests of lawmakers, physicians, patients, payers and industry at stake with potential significant cost/reimbursement and research budget cuts proposed has led me to thinking, without politicizing, how bizarre it all really can be. My first year of medical school a friend and I […]

Continue Reading

Adoption of Digital Pathology, Ford Model T and Electric Toothbrushes

| March 19, 2017 | 0 Comments

By Simon Häger, Product manager Sectra Digital Pathology Many pathology labs are currently switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. This transition is particularly strong in the Scandinavian countries and the Netherlands. It is highly likely that most labs throughout these regions will be completely digital within […]

Continue Reading

Tom Price Confirmed as HHS Secretary

| February 14, 2017 | 0 Comments

Congressman Tom Price, MD (R-GA) was confirmed as the Secretary of Health and Human Services (HHS) by the Senate on February 10, 2017. He was approved by a party-line vote of 52-47. Dr. Price will be the first physician to lead HHS since Dr. Louis W. Sullivan during the George H.W. Bush administration. Dr. Price, […]

Continue Reading

Trump Says ACA May Not Be Replaced Until Next Year

| February 6, 2017 | 0 Comments

Politico (2/5, Palmieri) reports that in an interview with Fox News’ Bill O’Reilly which aired before the Super Bowl, President Trump “walked back his recent vow that Obamacare would be replaced in short order,” saying that “the process is ‘complicated’ and ‘maybe it’ll take till sometime into next year.’” Trump said, “It statutorily takes a […]

Continue Reading

Understanding Reimbursement Changes in the U.S. and What They Mean to Your Anatomic Pathology (AP) Laboratory

| January 24, 2017 | 0 Comments

Save your spot to learn more about the effects of reimbursement changes in the US on the anatomic pathology market and in your laboratory You are invited to our next complimentary webinar – January 24, 2017 Understanding Reimbursement Changes in the U.S. and What They Mean to Your Anatomic Pathology (AP) Laboratory The United States […]

Continue Reading

Register Now for Upcoming Digital Pathology Association Webinar

| January 22, 2017 | 0 Comments

What to Expect for the Future of Regulatory Thursday, January 26, 2017 | 1 – 2 PM EST Presenter: Esther Abels Director Quality & Regulatory and Medical Affairs Philips Presentation Overview: Digital pathology is seen as bringing flexibility in the workflow and facilitating the pathologist to easier share information. DP has the potential to enhance cancer […]

Continue Reading

Patients Protest at Medical Conference

| December 11, 2016 | 0 Comments

It has been said there are only two certainties in life – death and taxes. Actually, there are a few more. The annual ASCO meeting always takes place during the first week of June, the annual RSNA meeting happens the week after Thanksgiving. The annual ASH meeting and the San Antonio Breast Cancer Symposium (SABCS) […]

Continue Reading

House Passes 21st Century Cures Act

| December 1, 2016 | 0 Comments

USA Today (11/30, Shesgreen, 5.28M) reports that the House on Wednesday approved the 21st Century Cures Act, a “sweeping health policy bill…aimed at sparking medical innovation, strengthening mental health services, and curbing the nation’s deadly opioid epidemic.” The legislation “cleared the House with broad bipartisan support, 392-to-26.” The New York Times (11/30, Steinhauer, Tavernise, Subscription Publication, 13.9M) says Senate passage […]

Continue Reading

FDA Delays Final Guidance on Regulating LDTs

| November 25, 2016 | 0 Comments

medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as “simple and scarce” as the article mentions, not before a draft guidance issued in 2014 has the FDA […]

Continue Reading